Immuneering investor relations
Witryna30 mar 2024 · Immuneering News: This is the News-site for the company Immuneering on Markets Insider WitrynaImmuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, colorectal, and non …
Immuneering investor relations
Did you know?
Witryna1 dzień temu · The presentations will be webcast live and archived for 30 days in the Investor Relations section of Immuneering’s website at Events & Presentations … Witryna20 maj 2024 · Forward-looking statements contained in this announcement are made as of this date, and Immuneering undertakes no duty to update such information except …
Witryna12 kwi 2024 · Format: Virtual Presentation and 1x1 Investor Meetings Virtual Presentation: April 19 from 12:45 - 1:25 pm ET in Track 1. The presentations will be … Witryna12 kwi 2024 · Format: Virtual Presentation and 1x1 Investor Meetings Virtual Presentation: April 19 from 12:45 - 1:25 pm ET in Track 1. The presentations will be …
Witryna27 lut 2024 · After the live webcast, the event will be archived for 90 days in the Investor Relations section of Immuneering's website at Events & Presentations. About … Witryna22 mar 2024 · See the latest Immuneering Corp Class A stock price (NASDAQ:IMRX), related news, valuation, dividends and more to help you make your investing …
Witryna1 dzień temu · Format: Virtual Presentation and 1x1 Investor Meetings. Virtual Presentation: April 19 from 12:45 - 1:25 pm ET in Track 1. The presentations will be webcast live and archived for 30 days in the Investor Relations section of Immuneering’s website at Events & Presentations Immuneering Corporation. …
Witryna9 lis 2024 · Forward-looking statements contained in this announcement are made as of this date, and Immuneering undertakes no duty to update such information except as required under applicable law. Corporate Contact: Rebecca Kusko, Ph.D. Immuneering Corporation 617-500-8080 [email protected]. Investor Contact: Anne … green hills bottle returnWitryna2 wrz 2024 · Press release content from Globe Newswire. The AP news staff was not involved in its creation. flvs music of the worldWitrynaFinancial statements and reports for Immuneering Corp USD0.001 A including annual reports and financial results for the last 5 years. ... Investor relations; Corporate … greenhills boys fc facebookWitryna23 mar 2024 · Immuneering Corporation (IMRX Quick Quote IMRX - Free Report) shares ended the last trading session 16.9% higher at $10.24. The jump came on an … greenhills boxing clubWitryna9 lis 2024 · Forward-looking statements contained in this announcement are made as of this date, and Immuneering undertakes no duty to update such information except as … flvs myworkday.comWitrynaImmuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling … flvs net worthWitryna6 mar 2024 · Immuneering Corporation (IMRX) delivered earnings and revenue surprises of 13.79% and 100%, respectively, for the quarter ended December 2024. … flvs national honor society